Literature DB >> 19889729

Syk expression in peripheral blood leukocytes, CD34+ progenitors, and CD34-derived basophils.

Susan S Ishmael1, Donald W MacGlashan.   

Abstract

In human basophils from different subjects, maximum IgE-mediated histamine release and the level of syk protein expression correlate well. It is not clear when in the basophil's lifetime the set-point for syk expression is reached or how expression levels are determined for a given individual. An examination of syk expression in peripheral blood eosinophils, neutrophils, monocytes, B and T cells, DCs, and NK cells showed that with the exception of T cells, basophils were unique in expressing low levels of syk. No correlations were observed between syk expression in basophils and other types of leukocytes, suggesting a unique mechanism of regulation for basophils. The expression level of syk in CD34+ progenitors was approximately 11-fold higher than in peripheral blood basophils, and it remained at this level during maturation of the cells in IL-3 to a cell with characteristics of peripheral blood basophils. Down-regulation of syk expression in the culture-derived basophils was induced by culturing under conditions of chronic aggregation of FcepsilonRI. Syk was down-regulated to peripheral blood basophil levels in 50% of the cells. Despite the chronic aggregation of FcepsilonRI, the cells retained the same expression of FcepsilonRI, histamine content, and morphological staining of granules as cells not experiencing chronic aggregation. These results suggest that chronic stimulation through FcepsilonRI during basophil maturation might be a mechanism for down-regulating syk expression, while retaining other characteristics associated with mature peripheral blood basophils.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19889729      PMCID: PMC2812559          DOI: 10.1189/jlb.0509336

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  37 in total

1.  The concept of basophil releasability.

Authors:  L M Lichtenstein; D W MacGlashan
Journal:  J Allergy Clin Immunol       Date:  1986-02       Impact factor: 10.793

2.  Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody.

Authors:  D W MacGlashan; B S Bochner; D C Adelman; P M Jardieu; A Togias; J McKenzie-White; S A Sterbinsky; R G Hamilton; L M Lichtenstein
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

3.  Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils.

Authors:  D MacGlashan; J M White; S K Huang; S J Ono; J T Schroeder; L M Lichtenstein
Journal:  J Immunol       Date:  1994-03-15       Impact factor: 5.422

4.  Measurement of IgE on human basophils: relation to serum IgE and anti-IgE-induced histamine release.

Authors:  M C Conroy; N F Adkinson; L M lichtenstein
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

5.  Early expression of high-affinity receptor for immunoglobulin E (Fc epsilon RI) during differentiation of mouse mast cells and human basophils.

Authors:  H L Thompson; D D Metcalfe; J P Kinet
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

6.  Nonreleasing basophils convert to releasing basophils by culturing with IL-3.

Authors:  M Yamaguchi; K Hirai; K Ohta; K Suzuki; S Kitani; T Takaishi; K Ito; C Ra; Y Morita
Journal:  J Allergy Clin Immunol       Date:  1996-06       Impact factor: 10.793

7.  Molecular cloning of human Syk. A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex.

Authors:  C L Law; S P Sidorenko; K A Chandran; K E Draves; A C Chan; A Weiss; S Edelhoff; C M Disteche; E A Clark
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

8.  The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.

Authors:  M Columbo; E M Horowitz; L M Botana; D W MacGlashan; B S Bochner; S Gillis; K M Zsebo; S J Galli; L M Lichtenstein
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

9.  The identification and characterization of umbilical cord blood-derived human basophils.

Authors:  C L Kepley; J R Pfeiffer; L B Schwartz; B S Wilson; J M Oliver
Journal:  J Leukoc Biol       Date:  1998-10       Impact factor: 4.962

10.  Human basophil releasability. III. Genetic control of human basophil releasability.

Authors:  G Marone; S Poto; D Celestino; S Bonini
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

View more
  15 in total

1.  The safety and efficacy of sublingual and oral immunotherapy for milk allergy.

Authors:  Corinne A Keet; Pamela A Frischmeyer-Guerrerio; Ananth Thyagarajan; John T Schroeder; Robert G Hamilton; Stephen Boden; Pamela Steele; Sarah Driggers; A Wesley Burks; Robert A Wood
Journal:  J Allergy Clin Immunol       Date:  2011-11-30       Impact factor: 10.793

2.  Autoantibodies to IgE and FcεRI and the natural variability of spleen tyrosine kinase expression in basophils.

Authors:  Donald MacGlashan
Journal:  J Allergy Clin Immunol       Date:  2018-06-01       Impact factor: 10.793

3.  Comprehensive population-based genome sequencing provides insight into hematopoietic regulatory mechanisms.

Authors:  Michael H Guo; Satish K Nandakumar; Jacob C Ulirsch; Seyedeh M Zekavat; Jason D Buenrostro; Pradeep Natarajan; Rany M Salem; Roberto Chiarle; Mario Mitt; Mart Kals; Kalle Pärn; Krista Fischer; Lili Milani; Reedik Mägi; Priit Palta; Stacey B Gabriel; Andres Metspalu; Eric S Lander; Sekar Kathiresan; Joel N Hirschhorn; Tõnu Esko; Vijay G Sankaran
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-28       Impact factor: 11.205

4.  The relationship between total cellular content of CD203c and cell surface expression on human basophils.

Authors:  V Alexander; D MacGlashan
Journal:  Clin Exp Allergy       Date:  2015-06       Impact factor: 5.018

5.  Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors.

Authors:  Donald W MacGlashan; Jessica H Savage; Robert A Wood; Sarbjit S Saini
Journal:  J Allergy Clin Immunol       Date:  2012-07-15       Impact factor: 10.793

Review 6.  IgE-dependent signaling as a therapeutic target for allergies.

Authors:  Donald W MacGlashan
Journal:  Trends Pharmacol Sci       Date:  2012-06-30       Impact factor: 14.819

7.  Stability of Syk protein and mRNA in human peripheral blood basophils.

Authors:  Donald MacGlashan
Journal:  J Leukoc Biol       Date:  2016-03-15       Impact factor: 4.962

8.  Regulation of Syk kinase and FcRbeta expression in human basophils during treatment with omalizumab.

Authors:  Asifa K Zaidi; Sarbjit S Saini; Donald W Macglashan
Journal:  J Allergy Clin Immunol       Date:  2010-03-17       Impact factor: 10.793

9.  Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune Diseases.

Authors:  Peter Blomgren; Jayaraman Chandrasekhar; Julie A Di Paolo; Wanchi Fung; Guoju Geng; Carmen Ip; Randall Jones; Jeffrey E Kropf; Eric B Lansdon; Seung Lee; Jennifer R Lo; Scott A Mitchell; Bernard Murray; Chris Pohlmeyer; Aaron Schmitt; Kimberly Suekawa-Pirrone; Sarah Wise; Jin-Ming Xiong; Jianjun Xu; Helen Yu; Zhongdong Zhao; Kevin S Currie
Journal:  ACS Med Chem Lett       Date:  2020-02-12       Impact factor: 4.345

10.  Roles of basophils and mast cells infiltrating the lung by multiple antigen challenges in asthmatic responses of mice.

Authors:  T Nabe; K Matsuya; K Akamizu; M Fujita; T Nakagawa; M Shioe; H Kida; A Takiguchi; H Wakamori; M Fujii; K Ishihara; S Akiba; N Mizutani; S Yoshino; D D Chaplin
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.